期刊文献+

全球药品短缺管理及其对我国的启示 被引量:14

Global Medicine Shortage Management and Its Implication for China
原文传递
导出
摘要 药品供应与百姓的健康福祉息息相关,是民生保障的重要内容。我国已经对部分易短缺药品采取定点生产等保障措施,但目前仍然面临原料药、儿童用药、部分临床必须小用量药品供应不足等一系列挑战。美国、加拿大等国家针对短缺药品已经制定了比较完善的管理办法。借鉴国际经验,明确药品短缺的定义,加强短缺药品管理,提出解决问题的政策建议,逐步完善我国药品供应保障体系。 Supply of medicines is closely associated with people's health and benefits. It is an important part of the goal tor ensuring people's well-being. Even though China has already taken several actions that consist of consigning certain manufacturers to produce medicines at a great risk of stock-outs, currently China is still facing a series of challenges including insufficient supply of API, pediatric medicines as well as some medicines of little usage amount. United States and Canada introduced sound policies for management of medicine shortage. By learning from international experience, it needs to clarify the definition of medicine shortage, enhance management of unavailable medicines, propose policy recommendation to solve the problem, and improve guarantee system for pharmaceutical supply gradually.
出处 《中国卫生经济》 北大核心 2016年第11期60-63,共4页 Chinese Health Economics
基金 国家卫生和计划生育委员会项目(01305)
关键词 药品短缺 供应保障 原料药 信息系统 medicine shortage supply guarantee active pharmaceutical ingredient information system
  • 相关文献

参考文献17

  • 1WEERDT E, SIMOENS S, CASTEELS M, et al. Toward a European definition for a drug shortage: a qualitative study [J]. Frontiers in pharmacology, 2015(6):253.
  • 2World Health Organization. Concept note of consuhation on managing global stock-outs of essential medicines[R]. Gene- va: World Health Organization, 2015.
  • 3International Pharmaceutical Federation. Report of the inter- national summit on medicine shortage[R]. Toronto: Interna- tional Pharmaceutical Federation, 2013.
  • 4LINK M, HAGERTY K, KANTARJIAN H. Chemotherapy drug shortages in the United States: Generics and potential solutions[J]. Journal of clinical oncology, 2012, 30(7) : 692-694.
  • 5NIXON H, PERAI.TA F. Drug shortages: where are we and where are we going[J]. American society of anesthesiologists, 2013,77(5) :20-22.
  • 6WEERDT E, SIMOENS S, HOMBROECKX L, et al. Causes of drug shortages in the legal pharmaceutical frame- work[J]. Regulatory toxicology and pharmacology, 2015, 1 (5):1-8.
  • 7SHADER R. Pediatric drug shortages: a deplorable fact and a political problem[J]. Clinical therapeutics, 2014, 36(2): 151-152.
  • 8GRAY A. Medicine shortages-unpicking the evidence from a year in South Africa[J]. Australian medical journal, 2014,7 (5) :208-212.
  • 9常峰,刘洪强.美国集中采购组织实施效果研究及其对我国药品采购的启示[J].中国卫生经济,2015,34(10):93-96. 被引量:11
  • 10FRISKE E. Addressing looming prescription drug shortages through legislative and regulatory approaches[R]. Minneso- ta: University of Minnesota, 2013.

二级参考文献28

  • 1龚时薇,张敏,邓秀玲,何惠君,李燕,王祎.对我国罕见病与罕用药界定的思考[J].中国新药杂志,2006,15(15):1225-1229. 被引量:20
  • 2李安然.2013年最畅销的25个药物[EB/OL].[ 2014-03 - 10] . http ://www.biodi scover, com/news/ industry/108426.html.
  • 3Hughes-Wilson W, Palma A, Schuurman A, et al. Paying for the orphan drug system: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments? E J]. Orphanet JRare Dis, 2012, 7: 74.
  • 4解读EVALUATEPHARMA2014年孤儿药报告[EB/OL].[2014-11-25]. http://news.bioon.com/article/6662458.html.
  • 5Franco P. Orphan drugs: the regulatory environment [J]. Drug Discovery Today, 2013, (18) : 163-172.
  • 6Hall AK, Carlson MR. The current status of orphan drug development in Europe and the US [J]. Intractable Rare Dis Res, 2014, 3 (1) : 1-7.
  • 7我国医药行业存在产能过剩问题[EB/OL].[2014-03-08].http://www.chinaim.com/news/20140308/102651496.html.
  • 8Global Market for Orphan Drugs is Expected to Reach $112 Billion in 2017 EEB/OL]. E2013-08-01]. http://www. drugs.com/news/global-market-orphan-expected-reach- 112- billion-2017-46799.html?utm_source=feedly.
  • 9Stamsnijder M. Living with progeria [J]. Orphanet J Rare Diseases, 2010, 5 (suppl 1): 1.
  • 10van Betuw A. The impact of a small parental network: how 1 lq improved research, knowledge, contacts and support [J]. OrphanetJRare Diseases, 2010, 5 (Suppl 1) : 8.

共引文献17

同被引文献80

引证文献14

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部